LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Article ; Online: Reduced DNAJC3 Expression Affects Protein Translocation across the ER Membrane and Attenuates the Down-Modulating Effect of the Translocation Inhibitor Cyclotriazadisulfonamide.

    Pauwels, Eva / Provinciael, Becky / Camps, Anita / Hartmann, Enno / Vermeire, Kurt

    International journal of molecular sciences

    2022  Volume 23, Issue 2

    Abstract: One of the reported substrates for the endoplasmic reticulum (ER) translocation inhibitor cyclotriazadisulfonamide (CADA) is DNAJC3, a chaperone of the unfolded protein response during ER stress. In this study, we investigated the impact of altered ... ...

    Abstract One of the reported substrates for the endoplasmic reticulum (ER) translocation inhibitor cyclotriazadisulfonamide (CADA) is DNAJC3, a chaperone of the unfolded protein response during ER stress. In this study, we investigated the impact of altered DNAJC3 protein levels on the inhibitory activity of CADA. By comparing WT DNAJC3 with a CADA-resistant DNAJC3 mutant, we observed the enhanced sensitivity of human CD4, PTK7 and ERLEC1 for CADA when DNAJC3 was expressed at high levels. Combined treatment of CADA with a proteasome inhibitor resulted in synergistic inhibition of protein translocation and in the rescue of a small preprotein fraction, which presumably corresponds to the CADA affected protein fraction that is stalled at the Sec61 translocon. We demonstrate that DNAJC3 enhances the protein translation of a reporter protein that is expressed downstream of the CADA-stalled substrate, suggesting that DNAJC3 promotes the clearance of the clogged translocon. We propose a model in which a reduced DNAJC3 level by CADA slows down the clearance of CADA-stalled substrates. This results in higher residual translocation into the ER lumen due to the longer dwelling time of the temporarily stalled substrates in the translocon. Thus, by directly reducing DNAJC3 protein levels, CADA attenuates its net down-modulating effect on its substrates.
    MeSH term(s) Endoplasmic Reticulum/metabolism ; Endoplasmic Reticulum Stress ; HEK293 Cells ; HSP40 Heat-Shock Proteins/metabolism ; Humans ; Protein Transport ; SEC Translocation Channels/metabolism ; Unfolded Protein Response
    Chemical Substances DNAJC3 protein, human ; HSP40 Heat-Shock Proteins ; SEC Translocation Channels
    Language English
    Publishing date 2022-01-06
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms23020584
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Inhibitors of the Sec61 Complex and Novel High Throughput Screening Strategies to Target the Protein Translocation Pathway.

    Pauwels, Eva / Schülein, Ralf / Vermeire, Kurt

    International journal of molecular sciences

    2021  Volume 22, Issue 21

    Abstract: Proteins targeted to the secretory pathway start their intracellular journey by being transported across biological membranes such as the endoplasmic reticulum (ER). A central component in this protein translocation process across the ER is the Sec61 ... ...

    Abstract Proteins targeted to the secretory pathway start their intracellular journey by being transported across biological membranes such as the endoplasmic reticulum (ER). A central component in this protein translocation process across the ER is the Sec61 translocon complex, which is only intracellularly expressed and does not have any enzymatic activity. In addition, Sec61 translocon complexes are difficult to purify and to reconstitute. Screening for small molecule inhibitors impairing its function has thus been notoriously difficult. However, such translocation inhibitors may not only be valuable tools for cell biology, but may also represent novel anticancer drugs, given that cancer cells heavily depend on efficient protein translocation into the ER to support their fast growth. In this review, different inhibitors of protein translocation will be discussed, and their specific mode of action will be compared. In addition, recently published screening strategies for small molecule inhibitors targeting the whole SRP-Sec61 targeting/translocation pathway will be summarized. Of note, slightly modified assays may be used in the future to screen for substances affecting SecYEG, the bacterial ortholog of the Sec61 complex, in order to identify novel antibiotic drugs.
    MeSH term(s) Animals ; Anti-Bacterial Agents/pharmacology ; Antineoplastic Agents/pharmacology ; Antiviral Agents/pharmacology ; Endoplasmic Reticulum/drug effects ; Endoplasmic Reticulum/metabolism ; High-Throughput Screening Assays ; Humans ; Protein Transport ; SEC Translocation Channels/antagonists & inhibitors ; SEC Translocation Channels/metabolism
    Chemical Substances Anti-Bacterial Agents ; Antineoplastic Agents ; Antiviral Agents ; SEC Translocation Channels
    Language English
    Publishing date 2021-11-05
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms222112007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Structural insights into TRAP association with ribosome-Sec61 complex and translocon inhibition by a CADA derivative.

    Pauwels, Eva / Shewakramani, Neesha R / De Wijngaert, Brent / Camps, Anita / Provinciael, Becky / Stroobants, Joren / Kalies, Kai-Uwe / Hartmann, Enno / Maes, Piet / Vermeire, Kurt / Das, Kalyan

    Science advances

    2023  Volume 9, Issue 9, Page(s) eadf0797

    Abstract: During cotranslational translocation, the signal peptide of a nascent chain binds Sec61 translocon to initiate protein transport through the endoplasmic reticulum (ER) membrane. Our cryo-electron microscopy structure of ribosome-Sec61 shows binding of an ...

    Abstract During cotranslational translocation, the signal peptide of a nascent chain binds Sec61 translocon to initiate protein transport through the endoplasmic reticulum (ER) membrane. Our cryo-electron microscopy structure of ribosome-Sec61 shows binding of an ordered heterotetrameric translocon-associated protein (TRAP) complex, in which TRAP-γ is anchored at two adjacent positions of 28
    MeSH term(s) SEC Translocation Channels ; Cryoelectron Microscopy ; Ribosomes ; Calcium-Binding Proteins
    Chemical Substances SEC Translocation Channels ; signal sequence receptor ; Calcium-Binding Proteins
    Language English
    Publishing date 2023-03-03
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2810933-8
    ISSN 2375-2548 ; 2375-2548
    ISSN (online) 2375-2548
    ISSN 2375-2548
    DOI 10.1126/sciadv.adf0797
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Small Molecule Cyclotriazadisulfonamide Abrogates the Upregulation of the Human Receptors CD4 and 4-1BB and Suppresses In Vitro Activation and Proliferation of T Lymphocytes.

    Claeys, Elisa / Pauwels, Eva / Humblet-Baron, Stephanie / Provinciael, Becky / Schols, Dominique / Waer, Mark / Sprangers, Ben / Vermeire, Kurt

    Frontiers in immunology

    2021  Volume 12, Page(s) 650731

    Abstract: The small molecule cyclotriazadisulfonamide (CADA) down-modulates the human CD4 receptor, an important factor in T cell activation. Here, we addressed the immunosuppressive potential of CADA using different activation models. CADA inhibited lymphocyte ... ...

    Abstract The small molecule cyclotriazadisulfonamide (CADA) down-modulates the human CD4 receptor, an important factor in T cell activation. Here, we addressed the immunosuppressive potential of CADA using different activation models. CADA inhibited lymphocyte proliferation with low cellular toxicity in a mixed lymphocyte reaction, and when human PBMCs were stimulated with CD3/CD28 beads, phytohemagglutinin or anti-CD3 antibodies. The immunosuppressive effect of CADA involved both CD4
    MeSH term(s) CD4 Antigens/metabolism ; CD4-Positive T-Lymphocytes/cytology ; CD4-Positive T-Lymphocytes/drug effects ; CD4-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/cytology ; CD8-Positive T-Lymphocytes/drug effects ; CD8-Positive T-Lymphocytes/immunology ; Cell Proliferation/drug effects ; Cells, Cultured ; Cytokines/immunology ; Cytokines/metabolism ; Endoplasmic Reticulum/drug effects ; Endoplasmic Reticulum/metabolism ; HEK293 Cells ; Humans ; Jurkat Cells ; Leukocytes, Mononuclear/cytology ; Leukocytes, Mononuclear/drug effects ; Leukocytes, Mononuclear/immunology ; Lymphocyte Activation/drug effects ; Lymphocyte Activation/immunology ; Protein Transport/drug effects ; STAT5 Transcription Factor/immunology ; STAT5 Transcription Factor/metabolism ; Small Molecule Libraries/chemistry ; Small Molecule Libraries/pharmacology ; Sulfonamides/chemistry ; Sulfonamides/pharmacology ; Tumor Necrosis Factor Receptor Superfamily, Member 9/metabolism ; Up-Regulation/drug effects
    Chemical Substances CD4 Antigens ; Cytokines ; STAT5 Transcription Factor ; Small Molecule Libraries ; Sulfonamides ; Tumor Necrosis Factor Receptor Superfamily, Member 9
    Language English
    Publishing date 2021-04-21
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2021.650731
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: A Proteomic Study on the Membrane Protein Fraction of T Cells Confirms High Substrate Selectivity for the ER Translocation Inhibitor Cyclotriazadisulfonamide.

    Pauwels, Eva / Rutz, Claudia / Provinciael, Becky / Stroobants, Joren / Schols, Dominique / Hartmann, Enno / Krause, Eberhard / Stephanowitz, Heike / Schülein, Ralf / Vermeire, Kurt

    Molecular & cellular proteomics : MCP

    2021  Volume 20, Page(s) 100144

    Abstract: Cyclotriazadisulfonamide (CADA) inhibits the cotranslational translocation of type I integral membrane protein human CD4 (huCD4) across the endoplasmic reticulum in a signal peptide (SP)-dependent way. Previously, sortilin was identified as a secondary ... ...

    Abstract Cyclotriazadisulfonamide (CADA) inhibits the cotranslational translocation of type I integral membrane protein human CD4 (huCD4) across the endoplasmic reticulum in a signal peptide (SP)-dependent way. Previously, sortilin was identified as a secondary substrate for CADA but showed reduced CADA sensitivity as compared with huCD4. Here, we performed a quantitative proteomic study on the crude membrane fraction of human T-cells to analyze how many proteins are sensitive to CADA. To screen for these proteins, we employed stable isotope labeling by amino acids in cell culture technique in combination with quantitative MS on CADA-treated human T-lymphoid SUP-T1 cells expressing high levels of huCD4. In line with our previous reports, our current proteomic analysis (data available via ProteomeXchange with identifier PXD027712) demonstrated that only a very small subset of proteins is depleted by CADA. Our data also confirmed that cellular expression of both huCD4 and sortilin are affected by CADA treatment of SUP-T1 cells. Furthermore, three additional targets for CADA are identified, namely, endoplasmic reticulum lectin 1 (ERLEC1), inactive tyrosine-protein kinase 7 (PTK7), and DnaJ homolog subfamily C member 3 (DNAJC3). Western blot and flow cytometry analysis of ERLEC1, PTK7, and DNAJC3 protein expression validated susceptibility of these substrates to CADA, although with varying degrees of sensitivity. Additional cell-free in vitro translation/translocation data demonstrated that the new substrates for CADA carry cleavable SPs that are targets for the cotranslational translocation inhibition exerted by CADA. Thus, our quantitative proteomic analysis demonstrates that ERLEC1, PTK7, and DNAJC3 are validated additional substrates of CADA; however, huCD4 remains the most sensitive integral membrane protein for the endoplasmic reticulum translocation inhibitor CADA. Furthermore, to our knowledge, CADA is the first compound that specifically interferes with only a very small subset of SPs and does not affect signal anchor sequences.
    MeSH term(s) Cell Line ; Endoplasmic Reticulum ; Humans ; Isotope Labeling ; Membrane Proteins/metabolism ; Proteomics ; Substrate Specificity ; Sulfonamides/pharmacology ; T-Lymphocytes/metabolism
    Chemical Substances Membrane Proteins ; Sulfonamides
    Language English
    Publishing date 2021-09-02
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2075924-1
    ISSN 1535-9484 ; 1535-9476
    ISSN (online) 1535-9484
    ISSN 1535-9476
    DOI 10.1016/j.mcpro.2021.100144
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Preprotein signature for full susceptibility to the co-translational translocation inhibitor cyclotriazadisulfonamide.

    Van Puyenbroeck, Victor / Pauwels, Eva / Provinciael, Becky / Bell, Thomas W / Schols, Dominique / Kalies, Kai-Uwe / Hartmann, Enno / Vermeire, Kurt

    Traffic (Copenhagen, Denmark)

    2019  Volume 21, Issue 2, Page(s) 250–264

    Abstract: Cyclotriazadisulfonamide (CADA) inhibits the co-translational translocation of human CD4 (huCD4) into the endoplasmic reticulum lumen in a signal peptide (SP)-dependent way. We propose that CADA binds the nascent huCD4 SP in a folded conformation within ... ...

    Abstract Cyclotriazadisulfonamide (CADA) inhibits the co-translational translocation of human CD4 (huCD4) into the endoplasmic reticulum lumen in a signal peptide (SP)-dependent way. We propose that CADA binds the nascent huCD4 SP in a folded conformation within the translocon resembling a normally transitory state during translocation. Here, we used alanine scanning on the huCD4 SP to identify the signature for full susceptibility to CADA. In accordance with our previous work, we demonstrate that residues in the vicinity of the hydrophobic h-region are critical for sensitivity to CADA. In particular, exchanging Gln-15, Val-17 or Pro-20 in the huCD4 SP for Ala resulted in a resistant phenotype. Together with positively charged residues at the N-terminal portion of the mature protein, these residues mediate full susceptibility to the co-translational translocation inhibitory activity of CADA towards huCD4. In addition, sensitivity to CADA is inversely related to hydrophobicity in the huCD4 SP. In vitro translocation experiments confirmed that the general hydrophobicity of the h-domain and positive charges in the mature protein are key elements that affect both the translocation efficiency of huCD4 and the sensitivity towards CADA. Besides these two general SP parameters that determine the functionality of the signal sequence, unique amino acid pairs (L14/Q15 and L19/P20) in the SP hydrophobic core add specificity to the sensitivity signature for a co-translational translocation inhibitor.
    MeSH term(s) CD4 Antigens/metabolism ; Endoplasmic Reticulum/metabolism ; Humans ; Hydrophobic and Hydrophilic Interactions ; Protein Processing, Post-Translational/drug effects ; Protein Sorting Signals/drug effects ; Protein Synthesis Inhibitors/pharmacology
    Chemical Substances CD4 Antigens ; Protein Sorting Signals ; Protein Synthesis Inhibitors
    Language English
    Publishing date 2019-11-25
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1483852-7
    ISSN 1600-0854 ; 1398-9219
    ISSN (online) 1600-0854
    ISSN 1398-9219
    DOI 10.1111/tra.12713
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Reduction of Progranulin-Induced Breast Cancer Stem Cell Propagation by Sortilin-Targeting Cyclotriazadisulfonamide (CADA) Compounds.

    Berger, Karoline / Pauwels, Eva / Parkinson, Gabrielle / Landberg, Göran / Le, Truc / Demillo, Violeta G / Lumangtad, Liezel A / Jones, Dylan E / Islam, Md Azizul / Olsen, Ryan / Kapri, Topprasad / Intasiri, Amarawan / Vermeire, Kurt / Rhost, Sara / Bell, Thomas W

    Journal of medicinal chemistry

    2021  Volume 64, Issue 17, Page(s) 12865–12876

    Abstract: Cyclotriazadisulfonamide (CADA) compounds selectively down-modulate two human proteins of potential therapeutic interest, cluster of differentiation 4 (CD4) and sortilin. Progranulin is secreted from some breast cancer cells, causing dedifferentiation of ...

    Abstract Cyclotriazadisulfonamide (CADA) compounds selectively down-modulate two human proteins of potential therapeutic interest, cluster of differentiation 4 (CD4) and sortilin. Progranulin is secreted from some breast cancer cells, causing dedifferentiation of receiving cancer cells and cancer stem cell proliferation. Inhibition of progranulin binding to sortilin, its main receptor, can block progranulin-induced metastatic breast cancer using a triple-negative in vivo xenograft model. In the current study, seven CADA compounds (CADA, VGD020, VGD071, TL020, TL023, LAL014, and DJ010) were examined for reduction of cellular sortilin expression and progranulin-induced breast cancer stem cell propagation. In addition, inhibition of progranulin-induced mammosphere formation was examined and found to be most significant for TL020, TL023, VGD071, and LAL014. Full experimental details are given for the synthesis and characterization of the four new compounds (TL020, TL023, VGD071, and DJ010). Comparison of solubilities, potencies, and cytotoxicities identified VGD071 as a promising candidate for future studies using mouse breast cancer models.
    MeSH term(s) Adaptor Proteins, Vesicular Transport/metabolism ; Antineoplastic Agents/chemical synthesis ; Antineoplastic Agents/chemistry ; Antineoplastic Agents/pharmacology ; Breast Neoplasms ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Drug Delivery Systems ; Drug Discovery ; Female ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Neoplastic Stem Cells/drug effects ; Progranulins/pharmacology ; Sulfonamides/chemistry ; Sulfonamides/pharmacology
    Chemical Substances Adaptor Proteins, Vesicular Transport ; Antineoplastic Agents ; Progranulins ; Sulfonamides ; sortilin (Z020Y8WIJ4)
    Language English
    Publishing date 2021-08-24
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 218133-2
    ISSN 1520-4804 ; 0022-2623
    ISSN (online) 1520-4804
    ISSN 0022-2623
    DOI 10.1021/acs.jmedchem.1c00943
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top